Journal
DNA AND CELL BIOLOGY
Volume 40, Issue 3, Pages 499-512Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/dna.2020.6320
Keywords
aggressive; inflammatory breast cancer; MiRNA; MicroRNA; OncomiR; tumor suppressor
Ask authors/readers for more resources
Inflammatory breast cancer (IBC) is a rare and highly aggressive type of breast cancer with unknown molecular mechanisms, requiring the identification of new biomarkers. MicroRNAs play important roles in IBC as diagnostic predictive tools.
Inflammatory breast cancer (IBC) as a rare and highly aggressive type of breast cancer displays phenotypic characteristics. To date, the IBC-associated molecular mechanisms are entirely unknown. In addition, there is an urgent need to identify the new biomarkers involved in the diagnosis and therapeutic purposes of IBC. MicroRNAs, a category of short noncoding RNAs, are capable of controlling the post-transcriptional expression of genes and thus can act as diagnostic predictive tools. In this review, we addressed the status of oncogenic and tumor suppressor miRNA-mediated IBC in current studies. Furthermore, based on their targets, their involvement in cancer progression, angiogenesis, metastasis, and apoptosis were determined.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available